Skip to main content
Log in

Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S)

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

An Erratum to this article was published on 01 May 2003

Abstract

The aim of this study was to investigate the direct involvement of hyperinsulinaemia, DHEA and DHEA-S [DHEA(S)] in severe obesity in early carotid atherosclerosis, measured as intima-media thickness (IMT). Seventeen normotensive premenopausal women with very high BMI (43.5±1.6 kg/m2) were recruited for the study. Six women were also evaluated 12 months after laparoscopic adjustable silicone gastric banding (LASGB). Dietary intake, fasting plasma lipid profile, glycemic and insulinemic response to the OGTT, adrenal secretion, at baseline and after ACTH stimulation test, were measured. IMT, common carotid diameter (CD) and left ventricular mass index (LVMi) were measured by B-mode echotomography. All obese subjects showed higher fasting and stimulated insulin levels, but lower DHEA(S) levels than controls, showing a negative correlation between both fasting and stimulated insulin and DHEA(S), either at baseline or after ACTH testing. IMT was higher (p<0.05) than controls, with a positive correlation with stimulated insulin (p<0.05) and a strong negative correlation with DHEA(S) (p<0.001). In a multiple linear regression analysis, insulin response to OGTT maintained an association with DHEA(S) independent of fasting insulin, while DHEA maintained the association with IMT independent of stimulated insulin (p<0.0001). In the six patients evaluated 12 months after LASGB, fasting insulin levels decreased, while DHEA(S) levels increased (p<0.05). In conclusion, an early cardiovascular involvement was detected in this group of severe obese with hyperinsulinaemia and low DHEA(S), even in the absence of other well known CVD risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Laakso M., Sarlund H., Salonen R., et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler. Thromb. 1991, 11: 1068–1076.

    Article  CAS  PubMed  Google Scholar 

  2. De Fronzo R.A., Ferrannini E.F. Insulin resistance: a multifactorial syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14: 173–194.

    Article  Google Scholar 

  3. Björntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 1997, 13: 795–803.

    Article  PubMed  Google Scholar 

  4. Seidell J.C. Time trends in obesity: an epidemiological perspective. Horm. Metab. Res. 1997, 29: 155–158.

    Article  CAS  PubMed  Google Scholar 

  5. Haffner SM. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Endocr. Rev. 1998, 19: 583–592.

    Article  CAS  PubMed  Google Scholar 

  6. Laakso M., Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 1998, 137: S65–73.

    Article  CAS  PubMed  Google Scholar 

  7. Wild R.A. Obesity, lipids, cardiovascular risk, and androgen excess. Am. J. Med. 1995, 16: 27S–32S.

    Article  Google Scholar 

  8. Khaw K.T. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. J. Endocrinol. 1996, 150: S149–153.

    Article  CAS  PubMed  Google Scholar 

  9. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 1997, 18: 774–800.

    CAS  PubMed  Google Scholar 

  10. Carmina E., Lobo R.A. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J. Clin. Endocrinol. Metab. 1999, 84: 1897–1899.

    Article  CAS  PubMed  Google Scholar 

  11. Nestler J.E. Regulation of human dehydroepiandrosterone metabolism by insulin. Ann. N. Y. Acad. Sci. 1995, 774: 73–81.

    Article  CAS  PubMed  Google Scholar 

  12. Yamaguchi Y., Tanaka S., Yamakawa T., et al. Reduced dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia. Clin. Endocrinol. (Oxf) 1998, 49: 377–383.

    Article  CAS  Google Scholar 

  13. Feldman H.A., Johannes C.B., McKinlay J.B., Longcope C. Low dehydroepiandrosterone sulfate and hearth disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study. Ann. Epidemiol. 1998, 8: 217–228.

    Article  CAS  PubMed  Google Scholar 

  14. Johannes C.B., Stellato R.K., Feldman H.A., Longcope C., McKinlay J.B. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women’s Health Study. J. Clin. Epidemiol. 1999, 52: 95–103.

    Article  CAS  PubMed  Google Scholar 

  15. De Pergola G., Giagulli V.A., Garruti G., et al. Low dehydroepiandrosterone circulating levels in premenopausal obese women with very high body mass index. Metabolism 1991, 40: 187–190.

    Article  PubMed  Google Scholar 

  16. De Pergola G., Zamboni M., Sciaraffia M., et al. Body fat accumulation is possibly responsible for lower dehydroepiandrosterone circulating levels in premenopausal obese women. Int. J. Obes. Relat. Metab. Disord. 1996, 20: 1105–1110.

    PubMed  Google Scholar 

  17. Orentreich N., Brind J., Rizer R., Vegelman J. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 1985, 59: 551–555.

    Article  Google Scholar 

  18. Barrett-Connor E., Ferrara A. Dehydroepiandrosterone, dehydro-epiandrosterone sulphate, obesity, waist-hip ratio, and noninsulin dependent diabetes in post-menopausal women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 1996, 81: 59–64.

    CAS  PubMed  Google Scholar 

  19. Ivandic A., Prpic-Krizevac I., Sucic M., Juric M. Hyperinsulinaemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity. Metabolism 1998, 47: 13–19.

    Article  CAS  PubMed  Google Scholar 

  20. Vicennati V., Calzoni F., Gambineri A., et al. Secretion of major adrenal androgens following ACTH administration in obese women with different body fat distribution. Horm. Metab. Res. 1998, 30: 133–136.

    Article  CAS  PubMed  Google Scholar 

  21. Maccario M., Mazza E., Ramunni J., et al. Relationships between dehydroepiandrosterone sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clin. Endocrinol. (Oxf.) 1999, 50: 595–600.

    Article  CAS  Google Scholar 

  22. Salonen J.T., Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler. Thromb. 1991, 11: 1245–1249.

    Article  CAS  PubMed  Google Scholar 

  23. De Luca N., Rosiello G., Lamenza F., et al. Reversal of cardiac and large artery structural abnormalities induced by long term antihypertensive treatment with trandolapril. Am. J. Cardiol. 1992, 70: 52–59.

    Article  Google Scholar 

  24. Crouse J.R. III, Craven T.E., Hagaman A.P., Bond M.G. Associations of coronary disease with segment specific intimal-medial thickening of the extracranial carotid artery. Circulation 1995, 92: 1141–1147.

    Article  PubMed  Google Scholar 

  25. Kuzmak L.I. A review of seven years’ experience with silicone gastric banding. Obes. Surg. 1991, 1: 403–408.

    Article  PubMed  Google Scholar 

  26. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20: 1183–1197.

    Google Scholar 

  27. Carnovale E., Marletta L. Tabelle di Composizione degli Alimenti. Istituto Nazionale della Nutrizione, Roma, 1997.

    Google Scholar 

  28. Wilkstrand J., Wendelhang I. Quantitative ultrasonography of carotid and femoral arteries. In: Lantzer P., Rösch J. (Eds.), Vascular diagnostics. Springer-Verlag, Heidelberg, 1994, pp.129–138

    Chapter  Google Scholar 

  29. National Institut of Health Consensus Development Conference Statement. Gastrointestinal Surgery for severe obesity. National Institutes of Health, Bethesda, MD, 1991.

    Google Scholar 

  30. Angrisani L., Lorenzo M., Esposito G., et al. Laparoscopic adjustable silicone gastric banding: preliminary results of Naples experience. Obes. Surg. 1997, 7: 19–21.

    Article  CAS  PubMed  Google Scholar 

  31. Moghetti P., Castello R., Negri C., et al. Insulin infusion amplifies 17a-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20 lyase activity. J. Clin. Endocrinol. Metab. 1996, 81: 881–886.

    CAS  PubMed  Google Scholar 

  32. De Pergola G., Ciccone M., Pannacciulli N., et al. Lower insulin sensitivity as an independent risk factor for carotid wall thickening in normotensive, non-diabetic, non-smoking normal weight and obese premenopausal women. Int. J. Obes. Relat. Metab. Disord. 2000, 24: 825–829.

    Article  PubMed  Google Scholar 

  33. Zietz B., Watzlawek E., Palitzsch K.D., Scholmerich J., Schaffler A. GG-genotype in the promotor region of uncoupling-protein-1 gene is associated with lower level of dehydroepiandrosterone in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 2001, 109: 102–106.

    Article  CAS  PubMed  Google Scholar 

  34. Clore J.N. Dehydroepiandrosterone and body fat. Obes. Res. 1995, 3: 613S–616S.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Silvia Savastano.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/BF03345190.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Savastano, S., Valentino, R., Belfiore, A. et al. Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). J Endocrinol Invest 26, 236–243 (2003). https://doi.org/10.1007/BF03345163

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345163

Key-words

Navigation